导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 36.88% | 115/1050 |
| 近一周 | 1.74% | 124/1104 |
| 近一月 | -1.29% | 271/1103 |
| 近一季 | -9.11% | 662/1092 |
| 近半年 | 25.40% | 117/1070 |
| 近一年 | 44.95% | 101/1018 |
| 近两年 | 121.92% | 149/926 |
| 近三年 | 72.30% | 155/834 |
| 成立以来 | 250.17% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.21% 502/1070 |
79.78% 109/1101 |
- - |
- - |
| 2025 | 38.21% 349/1065 |
-0.94% 856/1014 |
2.47% 471/1038 |
36.32% 259/1050 |
-0.12% 463/1065 |
| 2024 | -0.76% 600/1011 |
-2.13% 427/960 |
0.86% 250/983 |
4.80% 890/991 |
-4.06% 600/1011 |
| 2023 | -5.31% 208/952 |
13.67% 60/880 |
-4.06% 453/895 |
-5.38% 339/915 |
-8.24% 776/952 |
| 2022 | 31.50% 1/867 |
5.24% 1/773 |
11.96% 192/806 |
6.93% 3/845 |
4.36% 235/867 |
| 2021 | 13.22% 204/740 |
3.33% 74/580 |
0.23% 542/659 |
17.54% 22/704 |
-6.99% 624/740 |
| 2020 | 33.58% 335/554 |
-6.80% 336/419 |
4.20% 416/466 |
30.05% 6/517 |
5.76% 425/554 |
| 2019 | 23.89% 320/410 |
7.11% 1065/1146 |
8.30% 22/1228 |
-2.44% 363/390 |
9.48% 177/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 英大国企改革A VS. 东吴新产业精选股票A(580008) |